British and Italian doctors have carried out groundbreaking surgery to rebuild the windpipe of a 10-year-old British boy using stem cells developed within his own body, they said.

Includes BIIB, GENZ . Legendary activist investor, Carl Icahn, has made some big bets in the biotechnology sector. Two of his largest holdings are Genzyme (NASDAQ: GENZ) and Biogen Idec (NASDAQ: BIIB). Icahn's position in GENZ is worth around $235 million. His investment in Biogen is valued at over $688 million.

Bulgaria's parliament on Thursday tightened restrictions on genetically modified food crops in the face of pressure from environmentalists seeking a total ban.

SOFIA (Reuters) - Bulgaria's parliament voted on Thursday to tighten a law that effectively banned cultivation of genetically modified (GM) crops for scientific and commercial reasons in response to public fears.

Calif. judge allows genetically engineered beet harvest; amounts to half nation's sugar supply. A federal judge on Tuesday said farmers can harvest their genetically engineered sugar beets this year, ruling the economic impact too great and that environmental groups waited too long to request that the crop be yanked from the ground and otherwise barred from the market.

Genetically modified rice is being sold in supermarkets in China including US retail giant Wal-Mart, environmental group Greenpeace said in a report that contradicts government statements.

Sigma-Aldrich buys Ace Animals for undisclosed amount, adds lab rodent breeding resource. Biochemical company Sigma-Aldrich said Tuesday that it will buy a commercial rodent breeder in Pennsylvania.

Genetically modified rice is being sold in supermarkets in China including US retail giant Wal-Mart, environmental group Greenpeace said in a report that contradicts government statements.

American Oriental Bioengineering 4th-qtr profit up, but falls short of Wall Street estimates. Drug and nutritional product company American Oriental Bioengineering Inc. said Monday its profit climbed 49 percent in the fourth quarter due to reduced acquisition costs.

Biologists on Sunday said they had found a potential superweapon in a long-running arms race with bacteria that threaten essential crops.

ETFs could be your best bet . It was a "stealth" rally... Over the first couple months of 2010, the U.S. stock market hovered around breakeven. Investors were too busy worrying about Greece's debt crisis, fourth-quarter earnings, and health care reform to notice what was happening over in my corner of the market.

Aveo Pharmaceutical shares drop in trading debut, IPO raises $81 million. Shares of Aveo Pharmaceuticals are falling in their market debut, after its initial public offering raised $81 million.

Abbott Labs to pay $450 million for Facet Biotech, expand access to biotechnology drugs. Drug and medical products company Abbott Laboratories said Tuesday it will buy Facet Biotech Corp. for about $450 million in cash, expanding the company's access to biotechnology drugs, including a potential treatment for multiple sclerosis.

The United States will expose "troublesome" foreign trade barriers in a strategy to prise open markets for doubling American exports to create jobs, a top trade official said Tuesday.

Green members of the European parliament stood en masse and held up placards Tuesday in protest against the EU Commission approval of the cultivation of genetically modified potatoes.

PARIS (Reuters) - Europe's food safety agency has used partial evidence to approve genetically modified crops, including a GM potato developed by BASF, and should overhaul its methods, a French environment minister said.

Bristol-Myers expects profit of at least $1.95 a share in 2013, first full year without Plavix. Drugmaker Bristol-Myers Squibb Co. said Thursday it expects a profit of at least $1.95 per share in 2013, a crucial period because that's when U.S. generic competition will start wiping out sales of its top-selling medicine, the blood thinner Plavix.

Movers roundup: Imax falls as analyst eyes competition, RadioShack rises on takeover rumors. Among the stock activity stories for Wednesday, March 3, from AP Financial News:

European Parliament President Jerzy Buzek said on Wednesday he was against genetically-modified foods but said they were an unavoidable part of the future.

European Parliament President Jerzy Buzek said on Wednesday he was against genetically-modified foods but said they were an unavoidable part of the future.